Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer: A Nonrandomized Clinical Trial.
Journal: JAMA otolaryngology-- head & neck surgery
Published: June 18, 2026
Mutational Profile of Blood and Tumor Tissue and Biomarkers of Response to PD-1 Inhibitors in Patients with Cutaneous Squamous Cell Carcinoma.
Journal: Cancers
Published: February 03, 2025
Keratin-based topical cream for radiation dermatitis during head and neck radiotherapy: a randomised, open-label pilot study.
Journal: Journal of radiotherapy in practice
Published: October 04, 2024
Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.
Journal: Future oncology (London, England)
Published: May 18, 2023
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Journal: Therapeutic advances in medical oncology
Published: March 23, 2023
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature.
Journal: Therapeutic advances in medical oncology
Published: March 20, 2023
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2022
Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors.
Journal: Future oncology (London, England)
Published: June 14, 2022
Last Updated: 09/26/2026